MDS-4th Pan American Parkinson’s Disease and Movement Disorders Congress Plenary Sessions (Videos)

Description

Program Description

The MDS-4th Pan American Parkinson’s Disease and Movement Disorders Congress Plenary Sessions provides participants with access to six recorded Plenary Sessions that took place at the PAS Congress from May 26-28, 2022 in Miami, FL, USA. The topics covered in the six sessions include Diagnosis of Parkinson’s Disease, Tremor, Treatment of Parkinson’s Disease, Equity of Care – Underrepresented Populations in the Americas, Controversies in Movement Disorders, and Hot Topics in Movement Disorders: The Pan American Perspective.

Plenary Session 1: Diagnosis of Parkinson’s Disease

1. Diagnostic Biomarkers’s for Prodromal or Early Parkinson’s Disease | Lorraine Kaila
2. Definition of Early-Onset Parkinson’s Disease | Roy Alcalay
3. Diagnosis of Parkinson’s Disease Subtypes | Connie Marras

Plenary Session 2: Tremor

1. The Cerebellum in Essential Tremor: Primary Driver or Innocent Bystander? | Sheng-Han Kuo
2. Emerging Medical Therapies for Essential Tremor… Hope or Hype? | William Ondo
3. Diagnosis and Treatment of Dystonic Tremor, Vocal Tremor and Task-Specific Tremor… Controversy or Much Ado About Nothing? | Aasef Shaikh

Plenary Session 3: Treatment of Parkinson’s Disease

1. Current Medical Treatments for Parkinson’s Disease Across the Americas | Henrique Ferraz
2. Future Medical Treatment of Parkinson’s Disease |Tiago Mestre
3. Current and Future Surgical Treatments of Parkinson’s Disease | Helen Bronte-Stewart

Plenary Session 4: Equity of Care – Underrepresented Populations in the Americas

1. Race, Ethnicity and Gender in Parkinson’s Disease | Allison Willis
2. Reaching Underserved Populations in Parkinson’s Disease in North America | Britt Stone
3. Reaching Underserved Populations in Parkinson’s Disease in Latin America | Mayela Rodriguez Violante

Plenary Session 5: Controversies in Movement Disorders

1. Are we Close to a Cure for Huntington’s Disease? | Cristina Sampaio, Emailia Gatto
2. Can iPSC-Derived Models Replace Animal Models of Movement Disorders? | Birgitt Schuele, Serge Przedborski
3. Can Telemedicine Replace Traditional Medicine for Movement Disorders? | E. Ray Dorsey, Anthony Lang

Plenary Session 6: Hot Topics in Movement Disorders: The Pan-American Perspective

1. Past, Present and Future: Impact of COVID-19 on Parkinson’s Disease and Movement Disorders | Marcelo Merello
2. “Social Prescribing”: Mental and Physical Wellbeing in Parkinson’s Disease | Indu Subramanian
3. Why is our Approach Not Working in Disease Modification in Atypical Parkinsonisms | Irene Litvan

Credit Designation Statement:

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 10.5 AMA PRA Category 1 Credits™.